Phathom Pharmaceuticals (PHAT) Net Equity Issued and Repurchased (2018 - 2023)

Phathom Pharmaceuticals (PHAT) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $38.7 million in Q4 2023.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $38.7 million in Q4 2023; TTM through Sep 2024 was $38.7 million, a 0.07% change from a year earlier, with the FY2023 full-year figure at $14.1 million, down 42.78% from the prior year.
• Net Equity Issued and Repurchased for Q4 2023 stood at $38.7 million, up from $1000.0 in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for PHAT reached as high as $88.6 million in Q4 2020 and fell as low as $1000.0 in Q2 2023.
• Historically, Net Equity Issued and Repurchased has averaged $33.2 million across 3 years, with a median of $24.6 million in 2022.